Display options
Cite
Ryskina KL, Pesko MF, Gossey JT, et al. Brand Name Statin Prescribing in a Resident Ambulatory Practice: Implications for Teaching Cost-Conscious Medicine. J Grad Med Educ. 2014;6(3):484-8doi: 10.4300/JGME-D-13-00412.1.
Ryskina, K. L., Pesko, M. F., Gossey, J. T., Caesar, E. P., & Bishop, T. F. (2014). Brand Name Statin Prescribing in a Resident Ambulatory Practice: Implications for Teaching Cost-Conscious Medicine. Journal of graduate medical education, 6(3), 484-8. https://doi.org/10.4300/JGME-D-13-00412.1
Ryskina, Kira L, et al. "Brand Name Statin Prescribing in a Resident Ambulatory Practice: Implications for Teaching Cost-Conscious Medicine." Journal of graduate medical education vol. 6,3 (2014): 484-8. doi: https://doi.org/10.4300/JGME-D-13-00412.1
Ryskina KL, Pesko MF, Gossey JT, Caesar EP, Bishop TF. Brand Name Statin Prescribing in a Resident Ambulatory Practice: Implications for Teaching Cost-Conscious Medicine. J Grad Med Educ. 2014 Sep;6(3):484-8. doi: 10.4300/JGME-D-13-00412.1. PMID: 26279773; PMCID: PMC4535212.
Copy Download .nbib Format: NLM
Share it on

J Grad Med Educ. 2014 Sep;6(3):484-8. doi: 10.4300/JGME-D-13-00412.1.

Brand Name Statin Prescribing in a Resident Ambulatory Practice: Implications for Teaching Cost-Conscious Medicine.

Journal of graduate medical education

Kira L Ryskina, Michael F Pesko, J Travis Gossey, Erica Phillips Caesar, Tara F Bishop

PMID: 26279773 PMCID: PMC4535212 DOI: 10.4300/JGME-D-13-00412.1

Abstract

BACKGROUND: Several national initiatives aim to teach high-value care to residents. While there is a growing body of literature on cost impact of physicians' therapeutic decisions, few studies have assessed factors that influence residents' prescribing practices.

OBJECTIVE: We studied factors associated with intensive health care utilization among internal medicine residents, using brand name statin prescribing as a proxy for higher-cost care.

METHODS: We conducted a retrospective, cross-sectional analysis of statin prescriptions by residents at an urban academic internal medicine program, using electronic health record data between July 1, 2010, and June 30, 2011.

RESULTS: For 319 encounters by 90 residents, patients were given a brand name statin in 50% of cases. When categorized into quintiles, the bottom quintile of residents prescribed brand name statins in 2% of encounters, while the top quintile prescribed brand name statins in 98% of encounters. After adjusting for potential confounders, including patient characteristics and supervising attending, being in the primary care track was associated with lower odds (odds ratio [OR], 0.38; P  =  .02; 95% confidence interval [CI], 0.16-0.86), and graduating from a medical school with an above-average hospital care intensity index was associated with higher odds of prescribing brand name statins (OR, 1.70; P  =  .049; 95% CI, 1.003-2.88).

CONCLUSIONS: We found considerable variation in brand name statin prescribing by residents. Medical school attended and residency program type were associated with resident prescribing behavior. Future interventions should raise awareness of these patterns in an effort to teach high-value, cost-conscious care to all residents.

References

  1. Arch Intern Med. 2011 Aug 8;171(15):1385-90 - PubMed
  2. Acad Med. 2011 Jan;86(1):139-45 - PubMed
  3. Am J Cardiol. 1998 Mar 1;81(5):582-7 - PubMed
  4. J Grad Med Educ. 2010 Jun;2(2):175-80 - PubMed
  5. J Eval Clin Pract. 2010 Dec;16(6):1055-62 - PubMed
  6. JAMA. 1984 Jul 13;252(2):225-30 - PubMed
  7. N Engl J Med. 2010 Apr 8;362(14):1253-5 - PubMed
  8. Acad Med. 2012 Jun;87(6):719-28 - PubMed
  9. JAMA. 1981 Nov 13;246(19):2195-201 - PubMed
  10. Diabetes Obes Metab. 2005 Jul;7(4):430-8 - PubMed
  11. JAMA Intern Med. 2013 Feb 25;173(4):308-10 - PubMed
  12. Arch Intern Med. 2011 Nov 14;171(20):1856-8 - PubMed
  13. Ann Intern Med. 2011 Sep 20;155(6):386-8 - PubMed

Publication Types